Research Categories
- Anesthesia
- Arthroscopy
- Biologics/Biomaterials
- Cancer Devices
- Cardiovascular
- Cosmetic Devices
- Dental
- Diabetes
- Diagnostics
- Dialysis
- Drug Delivery
- Ear, Nose, Throat
- Endoscopy
- Gastrointestinal (GI)
- General Surgery
- Gynecology Devices
- Healthcare IT
- Hearing Devices
- Imaging
- Immunology
- Infusion Therapy
- Laparoscopy
- Minimally Invasive Surgery
- Neurology Devices
- Oncology
- Operating Room Equipment
- Ophthalmics Devices
- Orthopedics
- Patient Monitoring
- Peripheral Vascular
- Respiratory Devices
- Robotics & Navigation
- Sleep Apnea & Diagnostics
- Spine
- Stents
- Telehealth & Telemedicine
- Tissue Repair
- Urology
- Vascular Access
- Video Hi-Tech
- Women's Health
- Wound Care
Diabetes
The diabetes medical device market encompasses many different categories and sub-categories, and the disease continues to be a major problem. Even though uncertainties continue to plague the healthcare system in the U.S., the market should continue to trend upward in the coming years.
iData Research produces diabetes devices market reports that are unmatched in their depth and accuracy, providing healthcare companies of all sizes the necessary intelligence to help them determine their most effective strategies.
Showing all 2 results
Diabetes Monitoring, Treatment and Drug Delivery Market Size, Share & Trends Analysis | United States | 2025-2031 | MedSuite | Includes: Insulin & GLP-1, Continuous Glucose Monitoring and 7 more
Overall, the U.S. diabetes monitoring, treatment and drug delivery market was valued at nearly $48 billion in 2024. This is expected to increase over the forecast period at a CAGR of 7.3% to reach $79 billion in 2031. The full report suite on the U.S. market for diabetes monitoring, treatment and drug delivery includes blood […]
more...Diabetes Market Size, Share & Trends Analysis | Europe | 2019-2025 | MedSuite | Includes: Blood Glucose Meters, Blood Glucose Test Strips, Continuous Glucose Monitors and 6 more
The European diabetes monitoring, treatment, and drug delivery market, also referred to as the diabetes care market, includes blood glucose meters, blood glucose test strips, lancets, continuous glucose monitoring (CGM), flash glucose monitoring (FGM), insulin, insulin pens, insulin syringes, and insulin pumps. Previously, the European diabetes monitoring, treatment, and drug-delivery market was valued at €6.8 billion. […]
more...